CLINICAL_TRIALS
trial_result
· 2021-04-15
Clinical Trial Update: A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission [Phase 4]
Summary
Phase 4 clinical trial evaluating tofacitinib in ulcerative colitis patients in stable remission; study terminated with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Ulcerative Colitis | Phase 4 | Status: TERMINATED | Results posted: 2021-04-15